Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

Aims/hypothesis Using the Echantillon Généraliste de Bénéficiaires: random 1/97 permanent sample of the French national healthcare insurance system database (EGB), we investigated whether, as previously suspected, the risk of cancer in insulin glargine (A21Gly,B31Arg,B32Arg human insulin) users is h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetologia 2012-03, Vol.55 (3), p.644-653
Hauptverfasser:	Blin, P., Lassalle, R., Dureau-Pournin, C., Ambrosino, B., Bernard, M. A., Abouelfath, A., Gin, H., Le Jeunne, C., Pariente, A., Droz, C., Moore, N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Biological and medical sciences Breast cancer Cancer Chronic illnesses Cohort analysis Cohort Studies Databases, Factual Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - mortality Diabetes. Impaired glucose tolerance Disease Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female France - epidemiology Health care Human Physiology Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Incidence Insulin Insulin Glargine Insulin, Long-Acting - adverse effects Insulin, Long-Acting - therapeutic use Insurance Internal Medicine Male Medical sciences Medicine Medicine & Public Health Metabolic Diseases Metformin - adverse effects Metformin - therapeutic use Middle Aged Mortality National Health Programs Neoplasms - chemically induced Neoplasms - complications Neoplasms - epidemiology Patients Risk Sulfonylurea Compounds - adverse effects Sulfonylurea Compounds - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!